The designer antiangiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models-Reference-Cited by-同舟云学术

The designer antiangiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models

Published:2002-10-18 Issue:14 Volume:16 Page:1991-1993
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Schaft Daisy W. J.¹,Dings Ruud P. M.¹²,Lussanet Quido G.³,Eijk Loes I.¹,Nap Annemiek W.⁴,Beets‐Tan Regina G.H.³,Bouma‐Ter Steege Jessica C. A.¹,Wagstaff John¹,Mayo Kevin H.²,Griffioen Arjan W.¹⁵

Affiliation:

1. Angiogenesis Laboratory, Department of Internal MedicineResearch Institute for Growth and Development (GROW)

2. Dept. of BiochemistryUniversity of Minnesota Health Sciences Center Minneapolis MN

3. Dept. of RadiologyMaastricht University & University Hospital Maastricht Maastricht The Netherlands

4. Dept. of Obstetrics & GynecologyMaastricht University & University Hospital Maastricht Maastricht The Netherlands

5. Dept. of PathologyMaastricht University & University Hospital Maastricht Maastricht The Netherlands

Funder

National Institutes of Health

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.02-0509fje

Reference34 articles.

1. Rocking the foundations of solid tumor growth by attacking the tumor's blood supply

2. Angiogenesis in cancer, vascular, rheumatoid and other disease

3. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases and chronic inflammation;Griffioen A. W.;Pharmacol. Rev,2000

4. Definition of Two Angiogenic Pathways by Distinct α v Integrins

5. A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4.

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acquired Radiation Resistance Induces Thiol-dependent Cisplatin Cross-resistance;Radiation Research;2023-12-11

2. Targeting galectin-driven regulatory circuits in cancer and fibrosis;Nature Reviews Drug Discovery;2023-02-09

3. Immunoregulatory signal networks and tumor immune evasion mechanisms: insights into therapeutic targets and agents in clinical development;Biochemical Journal;2022-10-28

4. The chorioallantoic membrane as a bio-barrier model for the evaluation of nanoscale drug delivery systems for tumour therapy;Advanced Drug Delivery Reviews;2021-07

5. Targeting the CRD F‐face of Human Galectin‐3 and Allosterically Modulating Glycan Binding by Angiostatic PTX008 and a Structurally Optimized Derivative;ChemMedChem;2020-12